University of Gothenburg:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University of Gothenburg - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10504
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Gothenburg is an educational institute that offers medical education and research services. The institute provides undergraduate, postgraduate, degree programs, and distance education programs. It offers courses in the fields of natural sciences, education teaching and learning, medicine odontology health and care science, social and behavioural science, culture religion and history, languages, fine art design and crafts, information technology, business economics law and tourism, and music drama film and photography. The institute also operates departments for global studies, health and care sciences, historical studies, languages and literatures, marine sciences, mathematical sciences , odontology and social work, among others. University of Gothenburg is headquartered in Gothenburg, Sweden.

University of Gothenburg – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Gothenburg, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Gothenburg, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Gothenburg, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Gothenburg, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Gothenburg, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
University of Gothenburg, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Sprint Bioscience Enters into Co-Development Agreement with University of Gothenburg 10
Scandinavian Biopharma, PATH and University of Gothenburg Amend Agreement to Develop ETEC 11
Licensing Agreements 12
Oncorena Enters into Licensing Agreement with University of Gothenburg 12
University of Gothenburg – Key Competitors 13
University of Gothenburg – Key Employees 14
University of Gothenburg – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Government and Public Interest 16
Aug 16, 2018: Cardiovascular disease related to type 2 diabetes can be reduced significantly 16
Feb 28, 2018: RNA-based therapy cures lung cancer in mouse models 17
Sep 27, 2017: Grants to 18 research projects that may lead to future scientific breakthroughs 18
Sep 19, 2017: New treatment for osteoporosis provides better protection against fractures 22
Product News 23
Apr 16, 2018: A high-sensitive blood test when it is safe to return to play after a sports-related concussion 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
University of Gothenburg, Pharmaceuticals & Healthcare, Key Facts 2
University of Gothenburg, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Gothenburg, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Gothenburg, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Gothenburg, Deals By Therapy Area, 2012 to YTD 2018 8
University of Gothenburg, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sprint Bioscience Enters into Co-Development Agreement with University of Gothenburg 10
Scandinavian Biopharma, PATH and University of Gothenburg Amend Agreement to Develop ETEC 11
Oncorena Enters into Licensing Agreement with University of Gothenburg 12
University of Gothenburg, Key Competitors 13
University of Gothenburg, Key Employees 14
University of Gothenburg, Subsidiaries 15

List of Figures
University of Gothenburg, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Gothenburg, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Gothenburg, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Gothenburg, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Gothenburg, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Gothenburg, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of Gothenburg, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Gothenburg, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[University of Gothenburg:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KT Corporation:企業のM&A・事業提携・投資動向
    KT Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KT Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • IBERIABANK Corporation:企業のM&A・事業提携・投資動向
    IBERIABANK Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IBERIABANK Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Wm Morrison Supermarkets PLC:企業のM&A・事業提携・投資動向
    Wm Morrison Supermarkets PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wm Morrison Supermarkets PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd:企業の戦略的SWOT分析
    The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employee …
  • UniQure NV (QURE):製薬・医療:M&Aディール及び事業提携情報
    Summary UniQure NV (UniQure) develops and markets gene therapy products. The company develops adeno-associated virus based gene therapies using its gene technology platform. UniQure offers clinical and preclinical programs for lipoprotein lipase deficiency, hemophilia A and B, Huntington’s disease, …
  • UGE International Ltd (UGE):企業の財務・戦略的SWOT分析
    Summary UGE International Ltd (UGE), formerly Way Ventures Inc, is a renewable energy company that operates through wind, solar, solar-wind technologies. The company offers products such as electronics and accessories, wind turbines, solar panels, energy storage systems, mounting system, electronics …
  • Vikas WSP Ltd (519307):企業の財務・戦略的SWOT分析
    Vikas WSP Ltd (519307) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CVS Health Corp (CVS):企業の財務・戦略的SWOT分析
    CVS Health Corp (CVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bristol-Myers Squibb Co (BMY)-製薬・医療分野:企業M&A・提携分析
    Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and …
  • Chori Co Ltd (8014):企業の財務・戦略的SWOT分析
    Chori Co Ltd (8014) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • 4P-Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary 4P-Pharma SAS (4P-Pharma) focuses on the development of novel therapies for the treatment of cancer and inflammatory diseases. The company’s pipeline product portfolio includes new chemical entities, biologics, added value generics and fixed dose combinations. Its pipeline candidates targets …
  • RCS MediaGroup S.p.A. (RCS):企業の財務・戦略的SWOT分析
    RCS MediaGroup S.p.A. (RCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Allison Transmission Holdings Inc:企業の戦略・SWOT・財務情報
    Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • OncoSil Medical Ltd (OSL):企業の財務・戦略的SWOT分析
    Summary OncoSil Medical Ltd (OncoSil), is a medical device company that develops and commercializes products for the treatment of pancreatic and liver cancer. The company’s lead product includes oncosil, a brachytherapy device that emits beta radiation and is implanted directly inside the cancerous …
  • Pt Bakrieland Development Tbk:企業の戦略・SWOT・財務分析
    Pt Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Adamis Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向
    Adamis Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Adamis Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Coca-Cola FEMSA SAB de CV:戦略・SWOT・企業財務分析
    Coca-Cola FEMSA SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola FEMSA SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • University of York-製薬・医療分野:企業M&A・提携分析
    Summary University of York (York) is an educational and research university that offers academic research and teaching services. The university offers commercial facilities and services, funding collaborative research, knowledge transfer partnerships, professional development and training, consultan …
  • Scottish Enterprise:電力:M&Aディール及び事業提携情報
    Summary Scottish Enterprise is a business consulting firm that Supports firms to raise wage levels. The firm provides service such as attract investment, develop management team, do business outside Scotland, develop organization, develop new products and services, among others. It offers service su …
  • Ballard Power Systems Inc. (BLDP):企業の財務・戦略的SWOT分析
    Ballard Power Systems Inc. (BLDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆